The field of neuromodulation has entered a period of remarkable innovation and transformation, particularly through cutting-edge developments in spinal cord stimulation (SCS) technology. Between 2024 and 2025, significant strides in stimulation waveform engineering, closed-loop feedback mechanisms, and artificial intelligence integration have reshaped the therapeutic landscape. Once regarded primarily as a palliative intervention, SCS is now evolving into a dynamic and personalized form of therapy at the core of chronic pain and neurological disorder management. This review provides a comprehensive overview of the recent technological breakthroughs that have advanced the precision and adaptability of SCS devices. It explores the clinical efficacy evidence supporting these new systems, highlighting improvements in patient outcomes, device responsiveness, and long-term safety profiles. Furthermore, key challenges—such as variability in patient response, the need for improved biocompatibility, and ethical considerations surrounding AI-guided modulation—are critically examined. Finally, this paper discusses future directions for SCS research and development, envisioning a future where neuromodulation systems function as intelligent, self-optimizing therapeutic platforms capable of continuous adaptation to an individual’s neural and physiological state. Through these innovations, spinal cord stimulation stands poised to redefine the boundaries of neurotherapeutic care and establish a new standard for precision medicine in pain and neurological management.
B. Venkata Sushma*1, M. Sphurthy Mitra2, M. Jyoshna3, K. Susmitha4, D. Rehana5 (Wed,) studied this question.